Scientists project that by 2026 the results of clinical trials being conducted in 25 countries, including Spain, will be ...

Matthew Herper joins Adam and Allison to examine Prasad’s appointment and the band of outsiders now in charge of U.S. health ...

One year after Kristen Dahlgren chose to leave NBC News to focus on making breast cancer vaccines a reality, the journalist ...

Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, ...

IO Biotech's first-in-class vaccine performs double duty, killing cancer cells and enhancing the tumor microenvironment. A ...

Scientists have uncovered a promising new way to enhance the effectiveness of vaccines by tapping into the potential of a specific type of immune cell, opening the door to long-lasting vaccines for ...

Cancer is the leading cause of death in dogs. But there’s a vaccine being tested that could change that, and some of the ...

The phase 2B SURVIVE trial testing SurVaxM, a cancer vaccine for glioblastoma, will continue as planned following an interim analysis showing sufficient promise to proceed.

A new study seems to confirm that a single dose of the vaccine used to prevent HPV infection is just as effective as two — ...

The V Foundation for Cancer Research, a top-rated cancer charity, announced an exciting partnership with Cancer Vaccine Coalition (CVC), a groundbreaking non-profit focused on advancing cancer ...

So far, the vaccine has been given to 600 dogs at 11 clinics across the U.S., including two in Washington state.

These findings highlight specific patient groups who may benefit from targeted screening for anal HPV and anal cancer,” said lead study author Dr. Ashley Robinson.